Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Frontiers in Veterinary Science
|
August 9, 2021
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
Sara Saellstrom, Arian Sadeghi, Emma Eriksson, et al.
European Biophysics Journal : EBJ
|
June 22, 2010
Biophysical properties of Saccharomyces cerevisiae and their relationship with HOG pathway activation
Jörg Schaber, Miquel Angel Adrover, Emma Eriksson, et al.
Oncotarget
|
November 8, 2017
Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
Sandra Irenaeus, Aglaia Schiza, Sara M Mangsbo, et al.
Infection and Immunity
|
April 29, 2009
Nonhematopoietic cells control the outcome of infection with Listeria monocytogenes in a nucleotide oligomerization domain 1-dependent manner
Ahmed Mosa, Christian Trumstedt, Emma Eriksson, et al.
Biomarker Research
|
March 27, 2026
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
Hanna Grauers Wiktorin, Viktoria Ekström-Rydén, Ida Ek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor
Gustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2019
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor
Gustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2026
Tumor microenvironment gene engineering with LOAd703 in patients with solid malignancies: LOKON002 phase I/IIb clinical trial
Amanda Hahn, Sandra Irenaeus, Linda C Sandin, et al.
Faraday Discussions
|
September 18, 2024
Atomic-level structure of the amorphous drug atuliflapon <i>via</i> NMR crystallography
Jacob B Holmes, Daria Torodii, Martins Balodis, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Frontiers in Veterinary Science
|
August 9, 2021
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
Sara Saellstrom, Arian Sadeghi, Emma Eriksson, et al.
European Biophysics Journal : EBJ
|
June 22, 2010
Biophysical properties of Saccharomyces cerevisiae and their relationship with HOG pathway activation
Jörg Schaber, Miquel Angel Adrover, Emma Eriksson, et al.
Oncotarget
|
November 8, 2017
Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
Sandra Irenaeus, Aglaia Schiza, Sara M Mangsbo, et al.
Infection and Immunity
|
April 29, 2009
Nonhematopoietic cells control the outcome of infection with Listeria monocytogenes in a nucleotide oligomerization domain 1-dependent manner
Ahmed Mosa, Christian Trumstedt, Emma Eriksson, et al.
Biomarker Research
|
March 27, 2026
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
Hanna Grauers Wiktorin, Viktoria Ekström-Rydén, Ida Ek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor
Gustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2019
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor
Gustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2026
Tumor microenvironment gene engineering with LOAd703 in patients with solid malignancies: LOKON002 phase I/IIb clinical trial
Amanda Hahn, Sandra Irenaeus, Linda C Sandin, et al.
Faraday Discussions
|
September 18, 2024
Atomic-level structure of the amorphous drug atuliflapon <i>via</i> NMR crystallography
Jacob B Holmes, Daria Torodii, Martins Balodis, et al.
Page
of 5